Prognostic role of detailed colorectal location and tumor molecular features: analyses of 13,101 colorectal cancer patients including 2994 early-onset cases
Journal of Gastroenterology · 2023
DOI: 10.1007/s00535-023-01955-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology, 2023. Verfasst von Tomotaka Ugai und 45 weiteren Autor:innen. Beteiligte Einrichtung: Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, 221 Longwood Av…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Colonic Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NCI NIH HHS, Medical Research Council.
Themen: Onkologische Pflege
Abstract (Originalsprache)
BACKGROUND: The pathogenic effect of colorectal tumor molecular features may be influenced by several factors, including those related to microbiota, inflammation, metabolism, and epigenetics, which may change along colorectal segments. We hypothesized that the prognostic association of colon cancer location might differ by tumor molecular characteristics. METHODS: Utilizing a consortium dataset of 13,101 colorectal cancer cases, including 2994 early-onset cases, we conducted survival analyses of detailed tumor location stratified by statuses of microsatellite instability (MSI), CpG island methylator phenotype (CIMP), and KRAS and BRAF oncogenic mutation. RESULTS: There was a statistically significant trend for better colon cancer-specific survival in relation to tumor location from the cecum to sigmoid colon (Ptrend = 0.002), excluding the rectum. The prognostic association of colon location differed by MSI status (Pinteraction = 0.001). Non-MSI-high tumors exhibited the cecum-to-sigmoid trend for better colon cancer-specific survival [Ptrend < 0.001; multivariable hazard ratio (HR) for the sigmoid colon (vs. cecum), 0.80; 95% confidence interval (CI) 0.70-0.92], whereas MSI-high tumors demonstrated a suggestive cecum-to-sigmoid trend for worse survival (Ptrend = 0.020; the corresponding HR, 2.13; 95% CI 1.15-3.92). The prognostic association of colon tumor location also differed by CIMP status (Pinteraction = 0.003) but not significantly by age, stage, or other features. Furthermore, MSI-high status was a favorable prognostic indicator in all stages. CONCLUSIONS: Both detailed colonic location and tumor molecular features need to be accounted for colon cancer prognostication to advance precision medicine. Our study indicates the important role of large-scale studies to robustly examine detailed colonic subsites in molecular oncology research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, 221 Longwood Ave., EBRC Room 404, Boston, MA, 02215, USA. tugai@bwh.harvard.edu.
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. tugai@bwh.harvard.edu.
- Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, 221 Longwood Ave., EBRC Room 404, Boston, MA, 02215, USA.
- Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
- Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St Louis, MO, USA.
- Division of Gastroenterology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
ORCID-Profile: Shuji Ogino
Förderung
- NIH HHS
- NCI NIH HHS
- Medical Research Council
- Cancer Research UK
- World Health Organization
- Wellcome Trust
Zitieren
APA
Ugai, T., Akimoto, N., Haruki, K., Harrison, T. A., Cao, Y., Qu, C., Chan, A. T., Campbell, P. T., Berndt, S. I., Buchanan, D. D., Cross, A. J., Diergaarde, B., Gallinger, S. J., Gunter, M. J., Harlid, S., Hidaka, A., Hoffmeister, M., Brenner, H., Chang-Claude, J., …, & Ogino, S. (2023). Prognostic role of detailed colorectal location and tumor molecular features: analyses of 13,101 colorectal cancer patients including 2994 early-onset cases. Journal of Gastroenterology. https://doi.org/10.1007/s00535-023-01955-2
Vancouver
Ugai T, Akimoto N, Haruki K, Harrison TA, Cao Y, Qu C, et al. Prognostic role of detailed colorectal location and tumor molecular features: analyses of 13,101 colorectal cancer patients including 2994 early-onset cases. Journal of Gastroenterology. 2023. doi:10.1007/s00535-023-01955-2
BibTeX
@article{Ugai2023,
author = {Ugai, Tomotaka and Akimoto, Naohiko and Haruki, Koichiro and Harrison, Tabitha A and Cao, Yin and Qu, Conghui and Chan, Andrew T and Campbell, Peter T and Berndt, Sonja I and Buchanan, Daniel D and Cross, Amanda J and Diergaarde, Brenda and Gallinger, Steven J and Gunter, Marc J and Harlid, Sophia and Hidaka, Akihisa and Hoffmeister, Michael and Brenner, Hermann and Chang-Claude, Jenny and Hsu, Li and Jenkins, Mark A and Lin, Yi and Milne, Roger L and Moreno, Victor and Newcomb, Polly A and Nishihara, Reiko and Obon-Santacana, Mireia and Pai, Rish K and Sakoda, Lori C and Schoen, Robert E and Slattery, Martha L and Sun, Wei and Amitay, Efrat L and Alwers, Elizabeth and Thibodeau, Stephen N and Toland, Amanda E and Van Guelpen, Bethany and Zaidi, Syed H and Potter, John D and Meyerhardt, Jeffrey A and Giannakis, Marios and Song, Mingyang and Nowak, Jonathan A and Peters, Ulrike and Phipps, Amanda I and Ogino, Shuji},
title = {Prognostic role of detailed colorectal location and tumor molecular features: analyses of 13,101 colorectal cancer patients including 2994 early-onset cases},
journal = {Journal of Gastroenterology},
year = {2023},
doi = {10.1007/s00535-023-01955-2}
}
EUVIMED